Sobi has hit the acquisition trail with a deal to buy Arthrosi Therapeutics for up to $1.5 billion, adding a drug in late-stage clinical testing for gout. The deal, which includes a sizeable $950 ...

Athletics’ breakout star of 2025 is taking a gap year before university and says the break will help him focus more on the track Sprint phenomenon Gout Gout turned 18 on Monday, marking the formal end ...

Cases of gout are rising in younger individuals, according to a global study. The condition, which is a type of inflammatory arthritis, steadily increased in people aged 15 to 39 between 1990 and 2021 ...

Gout, the most common form of inflammatory arthritis, often coexists with comorbidities that require integrated assessment and treatment. The burden of cardiovascular-kidney-metabolic (CKM) ...

Please provide your email address to receive an email when new articles are posted on . Patients with gout were more likely than other patients to receive chronic opioids. Female sex, underweight BMI, ...

Gout Gout remains unfazed by constant comparisons to Usain Bolt, even from the man himself. Despite being widely tipped as the next global sprinting superstar, the 17-year-old is handling the pressure ...

Gout Gout is proving to be unfazed by constant comparisons to Usain Bolt, including from the man himself. The 17-year-old has been widely tipped to become the world’s next sprinting superstar but is ...

Gout patients shouldn't trust TikTok videos for advice on managing their condition, a new study says. Most videos portray gout flares as a personal choice that can be alleviated through a healthy diet ...

Most videos portray gout flares as a personal choice that can be alleviated through a healthy diet and less booze, researchers reported today in the journal Rheumatology Advances in Practice. The ...

Colchicine, a cheap and widely used gout drug, may help prevent heart attacks and strokes in people with cardiovascular disease. Trials involving nearly 23,000 patients show meaningful reductions in ...

SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Crystalys Therapeutics Inc. ('Crystalys' or 'the Company'), a clinical-stage biopharmaceutical company addressing the significant unmet medical needs of people ...